Oseltamivir Phosphate For Suspension
Product Images NDC 69097-904

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 69097-904). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oseltamivir Phosphate_carton Label (Oseltamivir Phosphate Carton Label)

Oseltamivir Phosphate_carton Label (Oseltamivir Phosphate Carton Label)
This is a prescription drug for oral suspension called Oseltamivir Phosphate. Once the powder is loosened with a certain amount of water, the oral suspension is ready to use. The suspension's usable volume is 60 mL, containing 360 mg of Oseltamivir free base, and it should be shaken well before use. The usual dosage and instructions should be referring to the package insert. The suspension can be stored for up to 17 days at 2°-8°C under refrigeration, and for up to 10 days at 25°C (77°F). It should be discarded after this period. The drug must be dispensed with a tamper-evident bottle, and patients must have an appropriate dosing device to ensure they correctly measure the oral suspension as prescribed. The text also contains batch identification numbers, manufacturing and distribution information.*
FDA Label Image

Oseltamivir Phosphate_label (Oseltamivir Phosphate Label)

FDA Label Image

Oseltamivir Phosphate_structure (Oseltamivir Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.